{
    "clinical_study": {
        "@rank": "18313", 
        "arm_group": [
            {
                "arm_group_label": "Propranolol", 
                "arm_group_type": "Active Comparator", 
                "description": "Propranolol by mouth given daily throughout hospitalization"
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo by mouth given daily throughout hospitalization"
            }
        ], 
        "brief_summary": {
            "textblock": "This efficacy and safety trial will examine the effects and safety of propranolol\n      administered to adult patients with severe burn injury. The investigators hypothesize that\n      propranolol will provide significant benefit to adults following severe burn injury at doses\n      that are safe and do not increase risk of adverse infectious and non-infectious outcomes."
        }, 
        "brief_title": "Protective Effects of Propranolol in Adults", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Burn", 
        "condition_browse": {
            "mesh_term": "Burns"
        }, 
        "detailed_description": {
            "textblock": "A safety and efficacy trial is needed in order to determine the safety of propranolol\n      treatment in adult burn patients, identify which subpopulations may be most likely to\n      benefit from propranolol treatment and to identify propranolol dose levels that are not only\n      safe but potentially effective."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265 20% Total Body Surface Area (TBSA) burn with anticipated operation need on\n             admission\n\n          -  Age \u2265 18 years\n\n          -  Admission within 72 hours of injury\n\n        Exclusion Criteria:\n\n          -  Age <18\n\n          -  Patients unlikely to survive injury or with ;age = total burn size \u2265 130\n\n          -  Electrical or deep chemical burn\n\n          -  Malignancy currently undergoing treatment or history of cancer treatment within 5\n             years\n\n          -  History of HIV or AIDS\n\n          -  Presence of anoxic brain injury that is not expected to result in complete recovery\n\n          -  Currently treated for Chronic Obstructive Pulmonary Disease (COPD), asthma or other\n             chronic pulmonary conditions\n\n          -  History of Congestive Heart Failure (CHF) (ejection fraction < 20%)\n\n          -  Pre-injury medications including blocking agents (alpha or beta) or other\n             anti-arrhythmic drugs\n\n          -  Pregnant women\n\n          -  Prisoners\n\n          -  History of cardiac arrhythmia requiring medication\n\n          -  Medical condition requiring glucocorticoid treatment\n\n          -  Patients with concurrent conditions that in the opinion of the investigator may\n             compromise patient safety or study objectives"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01902810", 
            "org_study_id": "12-205"
        }, 
        "intervention": [
            {
                "arm_group_label": "Propranolol", 
                "description": "Propranolol by mouth given daily throughout hospitalization", 
                "intervention_name": "Propranolol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "metroprolol", 
                    "inderol"
                ]
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "description": "Placebo by mouth given daily throughout hospitalization", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "control"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Propranolol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 12, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mozindw@surgery.ufl.edu", 
                    "last_name": "David Mozingo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gainsville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32610"
                    }, 
                    "name": "University of Florida"
                }, 
                "investigator": {
                    "last_name": "David Mozingo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "rgamelli@lumc.edu", 
                    "last_name": "Richard Gamelli, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Maywood", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60153"
                    }, 
                    "name": "Loyola University Burn Center"
                }, 
                "investigator": {
                    "last_name": "Richard Gamelli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "gerald-kealey@uiowa.edu", 
                    "last_name": "G Patrick Kealey, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242"
                    }, 
                    "name": "University of Iowa"
                }, 
                "investigator": {
                    "last_name": "G Patrick Kealey, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Sfagan@partners.org", 
                    "last_name": "Shawn Fagan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }, 
                "investigator": {
                    "last_name": "Shawn Fagan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "pbb2001@cornell.edu", 
                    "last_name": "Joe Bessey, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Cornell Burn Center"
                }, 
                "investigator": {
                    "last_name": "Joe Bassey, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Sidney.Miller@osumc.edu", 
                    "last_name": "Sidney Miller, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "Ohio State University"
                }, 
                "investigator": {
                    "last_name": "Sidney Miller, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "steven.wolf@utsouthwestern.edu", 
                    "last_name": "Steven Wolf, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "University of Texas, Southwestern"
                }, 
                "investigator": {
                    "last_name": "Steven Wolf, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Dbenjami@utmb.edu", 
                    "last_name": "Deb Benjamin, RN", 
                    "phone": "409-770-6731"
                }, 
                "contact_backup": {
                    "email": "ca2reed@utmb.edu", 
                    "last_name": "Cathy L Reed, BSN", 
                    "phone": "409-770-6987"
                }, 
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77551"
                    }, 
                    "name": "University of Texas Medical Branch"
                }, 
                "investigator": {
                    "last_name": "David Herndon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tpham94@uw.edu", 
                    "last_name": "Tam Pham, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98104"
                    }, 
                    "name": "University of Washington"
                }, 
                "investigator": {
                    "last_name": "Tam Pham, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Marc.Jeschke@sunnybrook.ca", 
                    "last_name": "Marc Jeschke, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "University of Toronto"
                }, 
                "investigator": {
                    "last_name": "Marc Jeschke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Protective Effects of Propranolol in Adults Following Major Burn Injury: A Safety and Efficacy Trial", 
        "overall_contact": {
            "email": "ca2reed@utmb.edu", 
            "last_name": "Catherine Reed, RN", 
            "phone": "409-7706987"
        }, 
        "overall_contact_backup": {
            "email": "dbenjami@utmb.edu", 
            "last_name": "Deb Benjamin, RN", 
            "phone": "409-770-6731"
        }, 
        "overall_official": {
            "affiliation": "University of Texas", 
            "last_name": "David N Herndon, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Multiply the subjects resting heart rate and blood pressure measurements as the average per 24 hours", 
            "measure": "Cardiac rate pressure product", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01902810"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "mortality rates will be compared between placebo group and propranolol treatment groups", 
            "measure": "Mortality rates", 
            "safety_issue": "Yes", 
            "time_frame": "time of randomization up to one year"
        }, 
        "source": "The University of Texas, Galveston", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Department of Defense", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "American Burn Association", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}